Swiss National Bank
ASMB icon

Swiss National Bank’s Assembly Biosciences ASMB Stock Holding History

Swiss National Bank’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-5,875
Closed -$324K – 2644
2021
Q1 		$324K Hold
5,875
– – ﹤0.01% 2472
2020
Q4 		$427K Hold
5,875
– – ﹤0.01% 2474
2020
Q3 		$1.16M Buy
5,875
+192
+3% +$48.3K ﹤0.01% 2009
2020
Q2 		$1.59M Buy
5,683
+1,141
+25% +$266K ﹤0.01% 1840
2020
Q1 		$808K Buy
4,542
+75
+2% +$16.1K ﹤0.01% 1949
2019
Q4 		$1.1M Buy
4,467
+909
+26% +$167K ﹤0.01% 2089
2019
Q3 		$420K Hold
3,558
– – ﹤0.01% 2405
2019
Q2 		$576K Buy
3,558
+266
+8% +$50.6K ﹤0.01% 2369
2019
Q1 		$778K Buy
3,292
+109
+3% +$27.6K ﹤0.01% 2203
2018
Q4 		$864K Buy
3,183
+258
+9% +$74.6K ﹤0.01% 2086
2018
Q3 		$1.3M Buy
2,925
+525
+22% +$246K ﹤0.01% 1989
2018
Q2 		$1.13M Hold
2,400
– – ﹤0.01% 2092
2018
Q1 		$1.42M Buy
2,400
+42
+2% +$26K ﹤0.01% 1869
2017
Q4 		$1.28M Buy
+2,358
New +$1.07M ﹤0.01% 1934

Other funds holding ASMB

AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Swiss National Bank's ASMB Position: Q2 2021 in Review

Swiss National Bank sold out of Assembly Biosciences (ASMB) in Q2 2021, closing a stake of 5,875 shares — an estimated $324K sold.

Swiss National Bank first reported a position in ASMB in Q4 2017 and held it in 14 quarters. The position peaked at $1.59M in Q2 2020. 91 funds tracked by Wall St. Rank hold ASMB as of Q2 2021.

  • Swiss National Bank reported no remaining Assembly Biosciences position as of Q2 2021 after selling out during the quarter.
  • Swiss National Bank sold 5,875 Assembly Biosciences shares in Q2 2021, an estimated $324K.
  • Swiss National Bank first reported a position in Assembly Biosciences in Q4 2017 and held it in 14 quarters.
  • Swiss National Bank's Assembly Biosciences position peaked at $1.59M in Q2 2020.
  • 91 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2021.

Based on Swiss National Bank's 13F filing for Q2 2021, filed 6 Aug 2021.